In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumonia
Mathieu Salaün, Francis Roussel, Geneviève Bourg-Heckly, Christine Vever-Bizet, Stéphane Dominique, Anne Genevois, Vincent Jounieaux, Gérard Zalcman, Emmanuel Bergot, Jean-Michel Vergnon, Luc Thiberville, Mathieu Salaün, Francis Roussel, Geneviève Bourg-Heckly, Christine Vever-Bizet, Stéphane Dominique, Anne Genevois, Vincent Jounieaux, Gérard Zalcman, Emmanuel Bergot, Jean-Michel Vergnon, Luc Thiberville
Abstract
Probe-based confocal laser endomicroscopy (pCLE) allows microscopic imaging of the alveoli during bronchoscopy. The objective of the study was to assess the diagnostic accuracy of pCLE for amiodarone-related pneumonia (AMR-IP). Alveolar pCLE was performed in 36 nonsmoking patients, including 33 consecutive patients with acute or subacute interstitial lung disease (ILD), of which 17 were undergoing treatment with amiodarone, and three were amiodarone-treated patients without ILD. Nine out of 17 patients were diagnosed with high-probability AMR-IP (HP-AMR-IP) by four experts, and three separate observers. Bronchoalveolar lavage findings did not differ between HP-AMR-IP and low-probability AMR-IP (LP-AMR-IP) patients. In HP-AMR-IP patients, pCLE showed large (>20 μm) and strongly fluorescent cells in 32 out of 38 alveolar areas. In contrast, these cells were observed in only two out of 39 areas from LP-AMR-IP patients, in one out of 59 areas from ILD patients not receiving amiodarone and in none of the 10 areas from amiodarone-treated patients without ILD (p<0.001; HP-AMR-IP versus other groups). The presence of at least one alveolar area with large and fluorescent cells had a sensitivity, specificity, negative predictive value and positive predictive value for the diagnosis of AMR-IP of 100%, 88%, 100% and 90%, respectively. In conclusion, pCLE appears to be a valuable tool for the in vivo diagnosis of AMR-IP in subacute ILD patients.
Trial registration: ClinicalTrials.gov NCT00213603.
Source: PubMed